Sriram Ryali - Mar 11, 2022 Form 4 Insider Report for Eiger BioPharmaceuticals, Inc. (EIGR)

Signature
/s/ Sriram Ryali
Stock symbol
EIGR
Transactions as of
Mar 11, 2022
Transactions value $
$0
Form type
4
Date filed
3/11/2022, 08:06 PM
Previous filing
Jul 30, 2021
Next filing
Mar 14, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EIGR Common Stock Award $0 +24K +121.02% $0.00 43.8K Mar 11, 2022 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EIGR Stock Option (Right to Buy) Award $0 +143K $0.00 143K Mar 11, 2022 Common Stock 143K $5.10 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares underlying Restricted Stock Units award that will vest as to 33.3% on each of the first, second and third anniversaries of the grant date of March 11, 2022.
F2 The option vests in 48 equal monthly installments commencing on the grant date of March 11, 2022, subject to the Reporting Person's continuous service as of such date.
F3 Includes shares purchased under the Issuer's Employee Stock Purchase Plans as follows: 434 shares on September 5, 2020, 585 shares on September 3, 2021, and 661 shares on March 5, 2022.